摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-Phenoxy-phenyl)-acrylsaeure-aethylester | 2509-20-8

中文名称
——
中文别名
——
英文名称
3-(4-Phenoxy-phenyl)-acrylsaeure-aethylester
英文别名
Ethyl p-phenoxycinnamate;ethyl 3-(4-phenoxyphenyl)prop-2-enoate
3-(4-Phenoxy-phenyl)-acrylsaeure-aethylester化学式
CAS
2509-20-8
化学式
C17H16O3
mdl
——
分子量
268.312
InChiKey
PWDOUGMRFQWZBH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:04134b0a597a85892a5001ed9708dc44
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(4-Phenoxy-phenyl)-acrylsaeure-aethylester甲苯 为溶剂, 反应 5.0h, 以80%的产率得到3-(4-phenoxyphenyl)propan-1-ol
    参考文献:
    名称:
    一种3-芳基丙醇的制备方法
    摘要:
    本发明公开了一种3‑芳基丙醇的制备方法,3‑芳基苯甲醛、乙酸酯在有机溶剂中,一定温度下加入催化剂进行缩合反应制备3‑芳基‑2‑烯酯,3‑芳基‑2‑烯酯和还原剂进行还原反应,最终得到产物3‑芳基丙醇。本发明方法采用芳氧基取代苯甲醛与乙酸酯缩合、再经过还原来制备3‑芳基丙醇,芳醛与乙酸酯在催化剂催化下进行缩合反应制备类似Knoevenagel缩合化合物3‑芳基‑2‑烯酯,再经过还原剂还原制备芳基丙醇,其总收率>80%,含量>95%;本发明使用的原料便宜、来源广,制备方法更加安全、方便,且生产成本低、原料无毒或低毒,总收率高且三废较少,有利于工业化。
    公开号:
    CN106554259B
  • 作为产物:
    描述:
    磷酰基乙酸三乙酯4-苯氧基苯甲醛 在 sodium hydride 作用下, 以 四氢呋喃 、 mineral oil 为溶剂, 反应 0.5h, 生成 3-(4-Phenoxy-phenyl)-acrylsaeure-aethylester
    参考文献:
    名称:
    Phosphonosulfonates Are Potent, Selective Inhibitors of Dehydrosqualene Synthase and Staphyloxanthin Biosynthesis in Staphylococcus aureus
    摘要:
    Staphylococcus aureus produces a golden carotenoid virulence factor called staphyloxanthin (STX), and we report here the inhibition of the enzyme, dehydrosqualene synthase (CrtM), responsible for the first committed step in STX biosynthesis. The most active compounds are halogen-substituted phosphonosulfonates, with K-i values as low as 5 nM against the enzyme and IC50 values for STX inhibition in S. aureus as low as 11 nM. There is, however, only a poor correlation (R-2 = 0.27) between enzyme and cell pIC(50) (= -log(10) IC50) values. The ability to predict cell from enzyme data improves considerably (to R-2 = 0.72) with addition of two more descriptors. We also investigated the activity of these compounds against human squalene synthase (SQS), as a counterscreen, finding several potent STX biosynthesis inhibitors with essentially no squalene synthase activity. These results open up the way to developing potent and selective inhibitors of an important virulence factor in S. aureus, a major human pathogen.
    DOI:
    10.1021/jm801023u
点击查看最新优质反应信息

文献信息

  • Isoxazole compounds useful for the prophylaxis or treatment of nervous
    申请人:Sankyo Company, Limited
    公开号:US06005116A1
    公开(公告)日:1999-12-21
    Isoxazole compounds having the following general formula: ##STR1## wherein R.sup.1 represents an optionally substituted aryl group or aromatic heterocyclic group; R.sup.2 represents a hydrogen atom, a halogen atom, an optionally substituted alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a cycloalkenyl group, an alkoxy group, a cyano group, a carboxyl group, an alkanoyl group, an alkoxycarbonyl group or an optionally substituted carbamoyl group; R.sup.3 represents an optionally substituted amino group or a saturated heterocyclic group; X represents an oxygen atom or a sulfur atom; and n is an integer of from 2 to 6. These compounds have excellent monoamine oxidase inhibitory activity and are useful as a therapeutic agent or a preventive agent against nervous diseases such as depression.
    具有以下一般式的异噁唑化合物:##STR1## 其中 R.sup.1 代表可选取代的芳基或芳香杂环基;R.sup.2 代表氢原子、卤原子、可选取代的烷基、烯基、炔基、环烷基、环烯基、烷氧基、氰基、羧基、酰基、烷氧羰基或可选取代的氨基甲酰基;R.sup.3 代表可选取代的氨基或饱和杂环基;X 代表氧原子或硫原子;n 为2到6的整数。这些化合物具有出色的单胺氧化酶抑制活性,并可用作治疗剂或预防神经疾病如抑郁症的药物。
  • Practical One-Pot Syntheses of Ethyl 4-Substituted-1<i>H</i>-Pyrrole-3-Carboxylates from Aldehydes
    作者:Jay Hyok Chang、Hyunik Shin
    DOI:10.1021/op7002826
    日期:2008.3.1
    Ethyl 4-substituted-1H-pyrrole-3-carboxylates were prepared in a one-pot manner starting from aromatic or aliphatic aldehydes via a Horner-Wadsworth-Emmons reaction and subsequent reaction with tosylmethylisocyanide (TosMIC) in the presence of sodium tert-amylate in toluene. Judicious selection of base and solvent led to the use of a single solvent, i.e., toluene, for reactions as well as for crystallization to render the one-pot process more practical and greener than the stepwise version.
  • Phosphonosulfonates Are Potent, Selective Inhibitors of Dehydrosqualene Synthase and Staphyloxanthin Biosynthesis in <i>Staphylococcus aureus</i>
    作者:Yongcheng Song、Fu-Yang Lin、Fenglin Yin、Mary Hensler、Carlos A. Rodrígues Poveda、Dushyant Mukkamala、Rong Cao、Hong Wang、Craig T. Morita、Dolores González Pacanowska、Victor Nizet、Eric Oldfield
    DOI:10.1021/jm801023u
    日期:2009.2.26
    Staphylococcus aureus produces a golden carotenoid virulence factor called staphyloxanthin (STX), and we report here the inhibition of the enzyme, dehydrosqualene synthase (CrtM), responsible for the first committed step in STX biosynthesis. The most active compounds are halogen-substituted phosphonosulfonates, with K-i values as low as 5 nM against the enzyme and IC50 values for STX inhibition in S. aureus as low as 11 nM. There is, however, only a poor correlation (R-2 = 0.27) between enzyme and cell pIC(50) (= -log(10) IC50) values. The ability to predict cell from enzyme data improves considerably (to R-2 = 0.72) with addition of two more descriptors. We also investigated the activity of these compounds against human squalene synthase (SQS), as a counterscreen, finding several potent STX biosynthesis inhibitors with essentially no squalene synthase activity. These results open up the way to developing potent and selective inhibitors of an important virulence factor in S. aureus, a major human pathogen.
  • 一种3-芳基丙醇的制备方法
    申请人:江苏扬农化工股份有限公司
    公开号:CN106554259B
    公开(公告)日:2019-05-21
    本发明公开了一种3‑芳基丙醇的制备方法,3‑芳基苯甲醛、乙酸酯在有机溶剂中,一定温度下加入催化剂进行缩合反应制备3‑芳基‑2‑烯酯,3‑芳基‑2‑烯酯和还原剂进行还原反应,最终得到产物3‑芳基丙醇。本发明方法采用芳氧基取代苯甲醛与乙酸酯缩合、再经过还原来制备3‑芳基丙醇,芳醛与乙酸酯在催化剂催化下进行缩合反应制备类似Knoevenagel缩合化合物3‑芳基‑2‑烯酯,再经过还原剂还原制备芳基丙醇,其总收率>80%,含量>95%;本发明使用的原料便宜、来源广,制备方法更加安全、方便,且生产成本低、原料无毒或低毒,总收率高且三废较少,有利于工业化。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐